Adaptive Biotechnologies attracts attention as immune medicine innovation, diagnostic advancements, and biotechnology expansion continue to shape the healthcare sector.

Since establishing MRD and Immune Medicine as separate operating segments under Adaptive in 2024, both businesses have continued to advance. MRD has achieved significant scale, expanded reimbursement, ...

Building upon a deep understanding of immune cell activation, researchers from Children's Hospital of Philadelphia (CHOP) developed a new artificial platform that can be used to induce T cell ...

Adaptive immunity is a central defence system essential for long-term and highly specific protection against pathogens through the precise molecular recognition of antigens by lymphocytes. However, ...

Detailed price information for Adaptive Biotechnologies Corp (ADPT-Q) from The Globe and Mail including charting and trades.

Adaptive Biotechnologies said on Monday it planned to separate its immune medicine ​business from its residual cancer-testing unit, ‌as it reviews options for the drug-discovery business and focuses ...

Proceeds expected to be deployed to repay the OrbiMed Purchase Agreement to enhance financial flexibility Additional proceeds used to pay for the ...

Dr. André Veillette told Newsweek that their findings could help patients who do not respond to current cancer treatments.

The immune system can be further classified into the innate and adaptive immune systems. Although innate myeloid cells, such as macrophages, generate a ‘trained’ immune response following antigen ...

Osteoarthritis (OA) is a chronic joint disease that has long been considered a simple wear-and-tear condition. Over the past decade, research has revealed that various inflammatory features of OA, ...